Stratos Wealth Advisors, LLC

Position in BMRN — Biomarin Pharmaceutical Inc

CIK 1707202 BEACHWOOD, OH

Position in BMRN

as of Mar 31, 2026 · filed Apr 28, 2026 Compact

Position Value

$1,174,766

-$61,140 QoQ

Shares Held

20,796

0.0% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.17%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Stratos Wealth Advisors, LLC holds $8,641,273 across 7 Biotechnology names. BMRN ranks #2 (13.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	8,695	$6,718,104
2	BMRN	Biomarin Pharmaceutical Inc This page	20,796	$1,174,766
3	TGTX	Tg Therapeutics, Inc.	8,022	$266,490
4	CRSP	CRISPR Therapeutics AG	5,365	$255,213
5	CADL	Candel Therapeutics, Inc.	25,908	$126,949
6	ABCL	AbCellera Biologics Inc.	23,000	$80,270
7	OSTX	OS Therapies Inc	13,817	$19,481

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,174,766	20,796	0.0%	Shares	Sole	2026-04-28
2025-12-31	$1,235,906	20,796	-22.6%	Shares	Sole	2026-01-20
2025-09-30	$1,455,279	26,870	-23.8%	Shares	Sole	2025-11-06
2025-06-30	$1,938,681	35,268	-1.1%	Shares	Sole	2025-07-29
2025-03-31	$2,521,370	35,668	-17.9%	Shares	Sole	2025-04-30
2024-12-31	$2,855,442	43,442	-0.9%	Shares	Sole	2025-01-27
2024-09-30	$3,081,654	43,842	-4.4%	Shares	Sole	2024-10-17
2024-06-30	$3,775,983	45,864	0.0%	Shares	Sole	2024-07-24
2024-03-31	$4,005,761	45,864	0.0%	Shares	Sole	2024-04-16
2023-12-31	$4,422,206	45,864	0.0%	Shares	Sole	2024-01-24
2023-09-30	$4,058,046	45,864	-5.3%	Shares	Sole	2023-10-24
2023-06-30	$4,196,525	48,414	+3.4%	Shares	Sole	2023-07-18
2023-03-31	$4,552,193	46,814	+26.3%	Shares	Sole	2023-04-27
2022-12-31	$3,835,235	37,059	—	Shares	Sole	2023-01-19
No filing history on record for this holder in this stock.